AI is inflating drug pipelines, with mixed results
An analysis questions whether AI-driven discovery is improving the quality of development candidates or simply enlarging them.
Read at The Clinical Trial Vanguard โAn analysis questions whether AI-driven discovery is improving the quality of development candidates or simply enlarging them.
Read at The Clinical Trial Vanguard โ